YAP1 and cancer: Specifically, high nuclear and cytoplasmic YAP1 immunoscores were detected in 70.7% (169/239) and 63.1% (125/216) of advanced cancers and 91.5% (65/71) and 100% (71/71) of CC samples, respectively (Figure 1A, Table S1).